-

03:59:23 PM

NMRD Stock News

NMRD - Nemaura Medical Inc

09/26/23 9:50 AM

Nasdaq : NMRD

managementAIlow float

Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.

Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today

RHEA-AI

neutral

09/18/23 9:15 AM

Nasdaq : NMRD

conferencesacquisitionlow float

Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference

Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz

RHEA-AI

neutral

09/14/23 8:00 AM

Nasdaq : NMRD

low float

Nemaura Medical Provides Update on Nasdaq Compliance Status and Process

Nemaura Medical, Inc.(Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today

RHEA-AI

positive

09/13/23 8:00 AM

Nasdaq : NMRD

low float

Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program

Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today

RHEA-AI

neutral

09/12/23 9:26 AM

Nasdaq : NMRD

low float

Nemaura Medical Announces Participation at HLTH 2023, Las Vegas

Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic devices and supporting diabetes management and personalized lifestyle coaching

RHEA-AI

neutral

09/11/23 9:00 AM

Nasdaq : NMRD

low float

Nemaura Medical Completes 100 Patient Study for sugarBEAT® 24-hour Wear and Reports Interim Results

Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized diabetes management and metabolic health programs,

RHEA-AI

neutral

08/17/23 8:30 AM

Nasdaq : NMRD

fda approvallow float

Nemaura Medical Announces SFDA Approval of sugarBEAT®

Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs,

RHEA-AI

neutral

08/14/23 8:30 AM

Nasdaq : NMRD

earningslow float

Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update

Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs,

RHEA-AI

neutral

08/11/23 4:05 PM

Nasdaq : NMRD

low float

Nemaura Medical Secures $6.5m in Non-Dilutive Funding

Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and supporting personalized digital coaching programs, announces today that it has secured a further

RHEA-AI

neutral

07/14/23 9:25 AM

Nasdaq : NMRD

earningslow float

Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023

Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs,

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 Next

NMRD Data

IndustrySurgical and Medical Instrument Manufacturing
Websitehttp://www.nemauramedical.com/
Security nameNemaura Medical Inc
SectorManufacturing
Tags
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
CountryUS

About Nemaura Medical Inc

nemaura medical inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. the company provides sugarbeat, a non-invasive continuous glucose monitoring device for use by persons with type i and type ii diabetes, as well as for screening pre-diabetic patients. it has a license agreement with healthimation, llc, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for type 2 diabetes, prediabetes, and general wellness; the why wait app; and common law trademarks which incorporate the mark why wait or whywait and the use of licensed marks. nemaura medical inc. was founded in 2009 and is based in new york, new york.